Barry Lipson, MD
Retina Specialist · San Diego, CANPI 1801903513
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,950 of the $3,667 with a category attached, or 80.4%. 8 manufacturers reported payments, led by Cardinal Health 108 LLC at 42.9% of the total. Reporting peaked in 2020 at $1,575 and has fallen 98.6% since, to $22 in 2024. That places this record below the midpoint for retina specialist clinicians in CA, where the typical reported total is $3,667.
Across 11 payments — averaging $333.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 108 LLC$2K
- Regeneron$1K
- Regeneron Healthcare Solutions, Inc.$375
- Bausch & Lomb, A Division Of Bausch Health US, LLC$93
- Dutch Ophthalmic, USA$91
- Novartis$79
- plus $79 from 2 others
What the payments were for
- Consulting fees$2,95080%
- Food & beverage$71720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 108 LLC | 1 | $1,575 |
| Regeneron | 1 | $1,375 |
| Regeneron Healthcare Solutions, Inc. | 3 | $375 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $93 |
| Dutch Ophthalmic, USA | 1 | $91 |
| Novartis | 1 | $79 |
| Carl Zeiss Meditec, Inc. | 1 | $58 |
| AbbVie | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$1,750
How this compares
$3,667 in reported general payments places this provider in the 50th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 11 | $7,764 |
| Prednisolone Acetate | 25 | $1,901 |
| Ketorolac Tromethamine | 39 | $1,403 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in San Diego
- Chirag ShahSan Diego$16K
- Thomas LazzariniSan Diego$15K
- Jason MossSan Diego$11K
- Delu SongSan Diego$10K
- Dilsher DhootSanta Barbara$1.9M
- Ehsan RahimyStanford$1.5M
- Darius MoshfeghiPalo Alto$1.4M
- Nathan SteinleSanta Barbara$1.1M
- Roger GoldbergWalnut Creek$1.1M
- Baruch KuppermannIrvine$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.